期刊文献+

便携式凝血自动检测仪快速抗凝测定与实验室常规抗凝测定的结果对比分析

Portable blood coagulation automatic detector rapid determination of anticoagulant and laboratory analysis of the results of the conventional anticoagulant
下载PDF
导出
摘要 目的通过便携式凝血自动检测仪快速抗凝测定与实验室常规抗凝测定的结果对比,观察快速抗凝测定检测结果的准确性.方法:对46 例260 人次心脏机械瓣膜置换术后患者采集静脉血进行实验室常规抗凝测定,同时采集末梢血进行床旁快速抗凝测定.结果:便携式凝血自动检测仪床旁快速抗凝测定与实验室常规抗凝测定结果相比较,差异无统计学意义(P〉0.05).结论:心脏机械瓣膜置换术后患者需进行抗凝治疗与监测,可以使用便携式INR 凝血自动检测仪进行快速抗凝测定以监测抗凝效果,从而提高心脏瓣膜置换术后患者抗凝监测的依从性,减少抗凝不当引起的并发症,提高瓣膜置换患者的术后生存率和生活质量. Objective through its coagulation automatic detector rapid determination of anticoagulation compared with the results of laboratory determination of conventionalanticoagulant, observe the accuracy of the testing results of rapid determination of anticoagulation.Methods: 46 cases of 260 patients after heart valve replacement venous blood wascollected for laboratory determination of conventional anticoagulant, collection of peripheral blood in bed fast determination of anticoagulation. Results: portable blood coagulationautomatic detector bedside rapid determination of anticoagulation compared with conventional laboratory anticoagulation determination results, there was no statistically significantdifference (P 〉 0.05).Conclusion: patients require anticoagulation therapy after heart valve replacement and monitoring, can use a portable INR blood coagulation detector for rapiddetermination of anticoagulant to monitor anticoagulant effect, thus improve the heart valve replacement patients after anticoagulation monitoring compliance, reduce the complicationsof anticoagulation improper, improve the postoperative survival rate and quality of life of patients with valve replacement.
出处 《中医学报》 CAS 2014年第B07期261-261,共1页 Acta Chinese Medicine
关键词 便携式凝血自动检测仪 心脏机械瓣膜置换 抗凝监测 依从性 Portable blood coagulation automatic detector Mechanical heart valve replacement Anticoagulation monitoring compliance
  • 相关文献

参考文献10

二级参考文献45

  • 1丛玉隆,伍平,殷宗健,张立文.血浆凝血因子测定的影响因素探讨[J].中华医学检验杂志,1995,18(2):75-77. 被引量:31
  • 2董力.心脏瓣膜替换术后的抗凝治疗[J].中华胸心血管外科杂志,1996,12(4):246-249. 被引量:22
  • 3Butchart EG, Li HH, Payne N, et al. Twenty years'experience with the Medtronic Hall valve [ J]. J Thorac Cardiovasc Surg, 2001, 121: 1090- 1100.
  • 4Aagaard J, Tingleff J, Hansen CN, et al. Twelve years' clinical experience with the CarboMedics prosthetic heart valve [ J ]. J Heart Valve Dis, 2001, 10: 177- 184.
  • 5Salem DN, Stein PD, A1 - Ahmad A, et al. Antithrombotic therapy in valvular heart disease- - native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [ J ]. Chest, 2004, 126: 457-482.
  • 6Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (war- farin) : thind edition - 2005 update [J]. Br J Haenaatol, 2006, 132: 277-285.
  • 7Moil T, Asano M, Ohtake H, et al. Anticoagulant therapy after prosthetic valve replacement- optinml PT- INR in Japanese patients [J]. Ann Thorac Cardiovasc Surg, 2002, 8: 83-87.
  • 8You JH, Chan FW, Wong RS, et al. Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate- intensity antieoagulation.9 [ J ] Br J Clin Phannaeol, 2005, 59 (5): 582-587.
  • 9Hirsh J, Fuster V, Ansell J, et al. American Heart Association/American Col- lege of Cardiology Foundation guide to warfarin therapy [ J ]. J Am Coil Cardiol, 2003, 41 (9) : 1633- 1652.
  • 10David MW, Chang P, David LA, et al. Comparison of plasma prothrombin and factor Ⅶ and urine prothrombin F1 concentration in palients on longterm warfarin therapy and those in the initial phase [ J ]. Am Hematol, 1998, 57:193- 199.

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部